These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 15534101)

  • 41. Comparison of the histological and immunohistochemical features of the thymus in young- and elderly-onset myasthenia gravis without thymoma.
    Ishii W; Matsuda M; Hanyuda M; Momose M; Nakayama J; Ehara T; Ikeda S
    J Clin Neurosci; 2007 Feb; 14(2):110-5. PubMed ID: 17113295
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Thymoma--clinical aspects and its biological function].
    Fujii Y
    Gan To Kagaku Ryoho; 2006 Nov; 33(11):1547-52. PubMed ID: 17108716
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Striational antibodies in a paraneoplastic context.
    McKeon A; Lennon VA; LaChance DH; Klein CJ; Pittock SJ
    Muscle Nerve; 2013 Apr; 47(4):585-7. PubMed ID: 23463255
    [TBL] [Abstract][Full Text] [Related]  

  • 44. New Purkinje cell antibody (PCA-2): marker of lung cancer-related neurological autoimmunity.
    Vernino S; Lennon VA
    Ann Neurol; 2000 Mar; 47(3):297-305. PubMed ID: 10716248
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Myotonic dystrophy type 1 coexisting with myasthenia gravis and thymoma.
    Feyma T; Carter GT; Weiss MD
    Muscle Nerve; 2008 Jul; 38(1):916-20. PubMed ID: 18563724
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel autoantibodies to a voltage-gated potassium channel Kv1.4 in a severe form of myasthenia gravis.
    Suzuki S; Satoh T; Yasuoka H; Hamaguchi Y; Tanaka K; Kawakami Y; Suzuki N; Kuwana M
    J Neuroimmunol; 2005 Dec; 170(1-2):141-9. PubMed ID: 16182377
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.
    Farrugia ME; Robson MD; Clover L; Anslow P; Newsom-Davis J; Kennett R; Hilton-Jones D; Matthews PM; Vincent A
    Brain; 2006 Jun; 129(Pt 6):1481-92. PubMed ID: 16672291
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Thymomatous epithelial cells and skeletal muscle share a common epitope defined by a monoclonal antibody.
    Dardenne M; Savino W; Bach JF
    Am J Pathol; 1987 Jan; 126(1):194-8. PubMed ID: 2433946
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thymoma-associated neuromyotonia with antibodies against voltage-gated potassium channels presenting as chronic intestinal pseudo-obstruction.
    Viallard JF; Vincent A; Moreau JF; Parrens M; Pellegrin JL; Ellie E
    Eur Neurol; 2005; 53(2):60-3. PubMed ID: 15753614
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acetylcholine receptor antibodies in myasthenia gravis are associated with greater risk of diabetes and thyroid disease.
    Toth C; McDonald D; Oger J; Brownell K
    Acta Neurol Scand; 2006 Aug; 114(2):124-32. PubMed ID: 16867036
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Coexistence of myasthenia gravis and serological markers of neurological autoimmunity in neuromyelitis optica.
    McKeon A; Lennon VA; Jacob A; Matiello M; Lucchinetti CF; Kale N; Chan KH; Weinshenker BG; Apiwattinakul M; Wingerchuk DM; Pittock SJ
    Muscle Nerve; 2009 Jan; 39(1):87-90. PubMed ID: 19086079
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Is excitation-contraction coupling impaired in myasthenia gravis?
    Nakata M; Kuwabara S; Kawaguchi N; Takahashi H; Misawa S; Kanai K; Tamura N; Sawai S; Motomura M; Shiraishi H; Takamori M; Maruta T; Yoshikawa H; Hattori T
    Clin Neurophysiol; 2007 May; 118(5):1144-8. PubMed ID: 17307394
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
    Cole RN; Reddel SW; Gervásio OL; Phillips WD
    Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quantitative EMG of facial muscles in myasthenia patients with MuSK antibodies.
    Farrugia ME; Kennett RP; Hilton-Jones D; Newsom-Davis J; Vincent A
    Clin Neurophysiol; 2007 Feb; 118(2):269-77. PubMed ID: 17157556
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sequential antibodies to potassium channels and glutamic acid decarboxylase in neuromyotonia.
    Antozzi C; Frassoni C; Vincent A; Regondi MC; Andreetta F; Bernasconi P; Ciano C; Chang T; Cornelio F; Spreafico R; Mantegazza R
    Neurology; 2005 Apr; 64(7):1290-3. PubMed ID: 15824370
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phenotypic variants of autoimmune peripheral nerve hyperexcitability.
    Hart IK; Maddison P; Newsom-Davis J; Vincent A; Mills KR
    Brain; 2002 Aug; 125(Pt 8):1887-95. PubMed ID: 12135978
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serologic profiles aiding the diagnosis of autoimmune gastrointestinal dysmotility.
    Dhamija R; Tan KM; Pittock SJ; Foxx-Orenstein A; Benarroch E; Lennon VA
    Clin Gastroenterol Hepatol; 2008 Sep; 6(9):988-92. PubMed ID: 18599359
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum antibodies and monoclonal antibodies secreted by thymic B-cell clones from patients with myasthenia gravis define striational antigens.
    Williams CL; Lennon VA; Momoi MY; Howard FM
    Ann N Y Acad Sci; 1987; 505():168-79. PubMed ID: 3500666
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Frequency of seronegativity in adult-acquired generalized myasthenia gravis.
    Chan KH; Lachance DH; Harper CM; Lennon VA
    Muscle Nerve; 2007 Nov; 36(5):651-8. PubMed ID: 17654558
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased expression of rapsyn in muscles prevents acetylcholine receptor loss in experimental autoimmune myasthenia gravis.
    Losen M; Stassen MH; Martínez-Martínez P; Machiels BM; Duimel H; Frederik P; Veldman H; Wokke JH; Spaans F; Vincent A; De Baets MH
    Brain; 2005 Oct; 128(Pt 10):2327-37. PubMed ID: 16150851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.